Abstract:
:Systems biology has matured considerably as a discipline over the last decade, yet some of the key challenges separating current research efforts in systems biology and clinically useful results are only now becoming apparent. As these gaps are better defined, the new discipline of systems medicine is emerging as a translational extension of systems biology. How is systems medicine defined? What are relevant ontologies for systems medicine? What are the key theoretic and methodologic challenges facing computational disease modeling? How are inaccurate and incomplete data, and uncertain biologic knowledge best synthesized in useful computational models? Does network analysis provide clinically useful insight? We discuss the outstanding difficulties in translating a rapidly growing body of data into knowledge usable at the bedside. Although core-specific challenges are best met by specialized groups, it appears fundamental that such efforts should be guided by a roadmap for systems medicine drafted by a coalition of scientists from the clinical, experimental, computational, and theoretic domains.
journal_name
Genome Medjournal_title
Genome medicineauthors
Clermont G,Auffray C,Moreau Y,Rocke DM,Dalevi D,Dubhashi D,Marshall DR,Raasch P,Dehne F,Provero P,Tegner J,Aronow BJ,Langston MA,Benson Mdoi
10.1186/gm88subject
Has Abstractpub_date
2009-09-29 00:00:00pages
88issue
9issn
1756-994Xpii
gm88journal_volume
1pub_type
杂志文章相关文献
Genome Medicine文献大全abstract:BACKGROUND:While clinical factors such as age, grade, stage, and histological subtype provide physicians with information about patient prognosis, genomic data can further improve these predictions. Previous studies have shown that germline variants in known cancer driver genes are predictive of patient outcome, but no...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/s13073-020-0718-7
更新日期:2020-02-17 00:00:00
abstract:BACKGROUND:The apolipoprotein E (APOE) ε4 allele is the strongest genetic risk factor for late onset Alzheimer's disease, whilst the ε2 allele confers protection. Previous studies report differential DNA methylation of APOE between ε4 and ε2 carriers, but associations with epigenome-wide methylation have not previously...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/s13073-020-00808-4
更新日期:2021-01-04 00:00:00
abstract:BACKGROUND:Intertumoral heterogeneity represents a significant hurdle to identifying optimized targeted therapies in gastric cancer (GC). To realize precision medicine for GC patients, an actionable gene alteration-based molecular classification that directly associates GCs with targeted therapies is needed. METHODS:A...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/s13073-017-0484-3
更新日期:2017-10-31 00:00:00
abstract:BACKGROUND:The advent of direct-to-consumer (DTC) genetic testing (GT) has sparked a number of debates regarding the scientific validity of tests, their broad health and ethical implications for society as well as their legal status. To date, relatively few empirical studies have been published regarding this phenomeno...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/gm449
更新日期:2013-05-22 00:00:00
abstract::The zebrafish model is rapidly gaining prominence in the study of development, hematopoiesis, and disease. The zebrafish provides distinct advantages over other vertebrate models during early embryonic development by producing transparent, externally fertilized embryos. Embryonic zebrafish are easily visualized and ma...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/gm299
更新日期:2011-12-29 00:00:00
abstract::The cancer genome is highly complex, with hundreds of point mutations, translocations, and chromosome gains and losses per tumor. To understand the effects of these alterations, precise models are needed. Traditional approaches to the construction of mouse models are time-consuming and laborious, requiring manipulatio...
journal_title:Genome medicine
pub_type: 杂志文章,评审
doi:10.1186/s13073-015-0178-7
更新日期:2015-06-09 00:00:00
abstract::Cutaneous malignancies, especially malignant melanoma, exhibit great genetic heterogeneity. As a result, some individuals and families have particularly increased risk due to genetic predisposition to the disease. The susceptibility alleles range from rarely occurring, heritable, high-risk variants to ubiquitously occ...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/gm95
更新日期:2009-10-27 00:00:00
abstract:BACKGROUND:Profiles of DNA methylation of many tissues relevant in human disease have been obtained from microarrays and are publicly available. These can be used to generate maps of chromatin compartmentalization, demarcating open and closed chromatin across the genome. Additionally, large sets of genome-wide transcri...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/s13073-017-0443-z
更新日期:2017-06-07 00:00:00
abstract:BACKGROUND:Retinoid therapy is widely employed in clinical oncology to differentiate malignant cells into their more benign counterparts. However, certain high-risk cohorts, such as patients with MYCN-amplified neuroblastoma, are innately resistant to retinoid therapy. Therefore, we employed a precision medicine approa...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/s13073-017-0407-3
更新日期:2017-02-10 00:00:00
abstract:BACKGROUND:Despite the increasing recognition that microbial communities within the human body are linked to health, we have an incomplete understanding of the environmental and molecular interactions that shape the composition of these communities. Although host genetic factors play a role in these interactions, these...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/s13073-018-0515-8
更新日期:2018-01-29 00:00:00
abstract:BACKGROUND:Antibiotic-resistant Klebsiella pneumoniae are a major cause of hospital- and community-acquired infections, including sepsis, liver abscess, and pneumonia, driven mainly by the emergence of successful high-risk clonal lineages. The K. pneumoniae sequence type (ST) 307 lineage has appeared in several differe...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/s13073-020-00814-6
更新日期:2020-12-09 00:00:00
abstract::Aberrant DNA methylation, in particular promoter hypermethylation and transcriptional silencing of tumor suppressor genes, has an important role in the development of many human cancers, including renal cell carcinoma (RCC). Indeed, apart from mutations in the well studied von Hippel-Lindau gene (VHL), the mutation fr...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/gm180
更新日期:2010-09-03 00:00:00
abstract:BACKGROUND:Hepatocellular carcinoma (HCC) is the one of the most common cancers and lethal diseases in the world. DNA methylation alteration is frequently observed in HCC and may play important roles in carcinogenesis and diagnosis. METHODS:Using the TCGA HCC dataset, we classified HCC patients into different methylat...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/s13073-018-0548-z
更新日期:2018-05-30 00:00:00
abstract::A genetic contribution to infectious disease in human populations has long been suspected and is now supported by more than 50 years of epidemiological evidence showing, for example, infection rates to be much higher than disease rates. In successful family studies of high-penetrance effects, single gene mutations hav...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/gm19
更新日期:2009-02-10 00:00:00
abstract:BACKGROUND:The human gut microbiome is associated with the development of colon cancer, and recent studies have found changes in the microbiome in cancer patients compared to healthy controls. Studying the microbial communities in the tumor microenvironment may shed light on the role of host-bacteria interactions in co...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/s13073-015-0177-8
更新日期:2015-06-24 00:00:00
abstract:BACKGROUND:Chemotherapeutic agents such as anthracyclines and taxanes are commonly used in the neoadjuvant setting. Bevacizumab is an antibody which binds to vascular endothelial growth factor A (VEGFA) and inhibits its receptor interaction, thus obstructing the formation of new blood vessels. METHODS:A phase II rando...
journal_title:Genome medicine
pub_type: 杂志文章,多中心研究,随机对照试验
doi:10.1186/s13073-018-0601-y
更新日期:2018-11-29 00:00:00
abstract::Whole genome sequencing is increasingly used to study phenotypic variation among infectious pathogens and to evaluate their relative transmissibility, virulence, and immunogenicity. To date, relatively little has been published on how and how many pathogen strains should be selected for studies associating phenotype a...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/s13073-014-0101-7
更新日期:2014-11-15 00:00:00
abstract::The pioneering work of Jean Dausset on the HLA system established several principles that were later reflected in the Human Genome Project and contributed to the foundations of predictive, preventive, personalized and participatory (P4) medicine. To effectively develop systems medicine, we should take advantage of the...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/gm178
更新日期:2010-08-26 00:00:00
abstract:BACKGROUND:As public health interventions drive parasite populations to elimination, genetic epidemiology models that incorporate population genomics can be powerful tools for evaluating the effectiveness of continued intervention. However, current genetic epidemiology models may not accurately simulate the population ...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/s13073-017-0398-0
更新日期:2017-01-24 00:00:00
abstract:BACKGROUND:Clinical laboratory (lab) tests are used in clinical practice to diagnose, treat, and monitor disease conditions. Test results are stored in electronic health records (EHRs), and a growing number of EHRs are linked to patient DNA, offering unprecedented opportunities to query relationships between genetic ri...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/s13073-020-00820-8
更新日期:2021-01-13 00:00:00
abstract::Next-generation sequencing (NGS) methodology allows for a major expansion in current carrier screening tests. NGS testing has been shown to be analytically accurate and cost-effective, but major challenges include educational and counseling issues. ...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/s13073-014-0062-x
更新日期:2014-08-26 00:00:00
abstract::Fecal microbiota transplantation (FMT) has demonstrated efficacy in treating inflammatory bowel diseases and irritable bowel syndrome in an increasing number of randomized controlled trials. Recently published data gives striking insights into the factors associated with FMT success paving the road for the use of prec...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/s13073-020-00757-y
更新日期:2020-06-30 00:00:00
abstract::The anticonvulsant carbamazepine has a high incidence of cutaneous adverse drug reactions. A recent prospective clinical trial in Taiwan has indicated that HLA-B*1502 screening will reduce the incidence of life-threatening adverse reactions to carbamazepine, while a genome-wide association study has identified the HLA...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/gm243
更新日期:2011-05-30 00:00:00
abstract:BACKGROUND:The R620W variant in protein tyrosine phosphatase non-receptor 22 (PTPN22) is associated with rheumatoid arthritis (RA). The PTPN22 gene has alternatively spliced transcripts and at least two of the splice forms have been confirmed to encode different PTPN22 (LYP) proteins, but detailed information regarding...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/gm301
更新日期:2012-01-20 00:00:00
abstract::Considerable time and effort has been spent in developing analysis and quality assessment methods to allow the use of microarrays in a clinical setting. As is the case for microarrays and other high-throughput technologies, data from new high-throughput sequencing technologies are subject to technological and biologic...
journal_title:Genome medicine
pub_type: 社论
doi:10.1186/gm208
更新日期:2010-12-10 00:00:00
abstract:BACKGROUND:Establishing the cancer type and site of origin is important in determining the most appropriate course of treatment for cancer patients. Patients with cancer of unknown primary, where the site of origin cannot be established from an examination of the metastatic cancer cells, typically have poor survival. H...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/s13073-017-0493-2
更新日期:2017-11-28 00:00:00
abstract::The role of ezetimibe in lowering plasma cholesterol has been established; however, controversy remains about its clinical benefit. A recent study utilizes naturally occurring genetic variation within the NPC1-like 1 gene (NPC1L1) to demonstrate the potential for pharmacologic inhibition of the protein to reduce the r...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/s13073-015-0130-x
更新日期:2015-01-28 00:00:00
abstract:BACKGROUND:Enterococcus faecium is a commensal of the gastrointestinal tract of animals and humans but also a causative agent of hospital-acquired infections. Resistance against glycopeptides and to vancomycin has motivated the inclusion of E. faecium in the WHO global priority list. Vancomycin resistance can be confer...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/s13073-020-00825-3
更新日期:2021-01-20 00:00:00
abstract::Accurate interpretation of gene testing is a key component in customizing patient therapy. Where confirming evidence for a gene variant is lacking, computational prediction may be employed. A standardized framework, however, does not yet exist for quantitative evaluation of disease association for uncertain or novel g...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/gm347
更新日期:2012-05-28 00:00:00
abstract:BACKGROUND:Phenotypic changes during cancer progression are associated with alterations in gene expression, which can be exploited to build molecular signatures for tumor stage identification and prognosis. However, it is not yet known whether the relative abundance of transcript isoforms may be informative for clinica...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/s13073-016-0339-3
更新日期:2016-08-17 00:00:00